Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for general anesthesia in obese patients
ChiCTR2600121837Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in obesity (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Incidence of cardiac and pulmonary complications during hospitalization and Perioperative hypotensive events (MAP <65 mmHg area under the curve). Planned start Apr 2026; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
obesity
Beyond the preview
Go deeper on ChiCTR2600121837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600121837.